EyePoint Pharmaceuticals, Inc.
NASDAQ: EYPT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jay S. Duker
- Employees
- 165
- Headquarters
- Watertown, United States
- IPO year
- 2005
- Market cap
- $1.2B
- Website
- https://eyepointpharma.com
Loading EYPT…
Loading profile data…Frequently asked questions about EYPT
What does EyePoint Pharmaceuticals, Inc. (EYPT) do?
EyePoint Pharmaceuticals, Inc. is a pharmaceutical firm dedicated to the creation and marketing of ophthalmic solutions for various eye ailments. Its operations span the United States, China, and the United Kingdom. Among its commercialized product portfolio are ILUVIEN, an injectable, sustained-release micro-insert designed to treat diabetic ma...
Where does EYPT trade?
EyePoint Pharmaceuticals, Inc. (EYPT) trades on the NASDAQ Global Market.
What sector is EYPT in?
EyePoint Pharmaceuticals, Inc. (EYPT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of EyePoint Pharmaceuticals, Inc.?
Jay S. Duker is the chief executive officer of EyePoint Pharmaceuticals, Inc. (EYPT).
Where is EyePoint Pharmaceuticals, Inc. headquartered?
EyePoint Pharmaceuticals, Inc. is headquartered in United States.
Does EYPT pay a dividend?
EyePoint Pharmaceuticals, Inc. (EYPT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EYPT go public?
EyePoint Pharmaceuticals, Inc. (EYPT) completed its initial public offering in 2005.